loader
Please Wait
Applying Filters...

Looking for Viibryd? Find Controlled & Modified Release used in Viibryd to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 4,807Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SPI Pharma

02 5Nanjing Well Pharmaceutical

03 2Actylis

04 2Aeon Procare

05 8BASF

06 4Finar

07 1Ideal Cures

08 3Kerry

09 2Nomisma Healthcare

10 1Sigachi Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

03

arrow
Aus. Peptide Conference
Not Confirmed

04

arrow
Aus. Peptide Conference
Not Confirmed

05

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank